Biogen Idec - PDFSEARCH.IO - Document Search Engine

Biogen Idec
Results: 183

#	Item
101	Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-02-17 10:44:24 Élan Progressive multifocal leukoencephalopathy Health Medicine IDEC Pakistan Muslim League Biology Immunosuppressants Natalizumab Biogen Idec
102	Biogen Idec (Labeler Code[removed]Re-Calculation of 340B Ceiling Prices for Q3 2005 through Q3 2007 Add to Reading List Source URL: www.hrsa.gov Language: English - Date: 2012-10-04 17:58:42 Medicaid Biology Economy of the United States Biogen Idec IDEC Interferon beta-1a
103	Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waivers under 18 U Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-02-17 10:44:23 Élan Progressive multifocal leukoencephalopathy IDEC Health Medicine Biology Immunosuppressants Natalizumab Biogen Idec
104	Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waivers under 18 U Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-02-17 10:44:24 Élan Progressive multifocal leukoencephalopathy Health Medicine IDEC Biology Immunosuppressants Natalizumab Biogen Idec
105	Microsoft Word[removed]NOV Tysabri webcast.doc Add to Reading List Source URL: www.fda.gov Language: English Immunology Natalizumab Multiple sclerosis Progressive multifocal leukoencephalopathy Biogen Idec Food and Drug Administration JC virus Immunosuppressants Health Medicine
106	TYSABRI® RISK MINIMIZATION ACTION PLAN: SUMMARY OF TOUCHSM Add to Reading List Source URL: www.fda.gov Language: English Natalizumab Biogen Idec Pharmacology Medical prescription Progressive multifocal leukoencephalopathy Medicine Health Immunosuppressants
107	DRAFT Appeal Letter – Tecfidera TODAY’s DATE Health Plan Addressee Line 1 Health Plan Addressee Line 2 Add to Reading List Source URL: www.nationalmssociety.org Language: English - Date: 2014-01-15 23:48:04 Health Glatiramer acetate Biogen Idec Dimethyl fumarate Placebo Therapies under investigation for multiple sclerosis Corinne Goldsmith Dickinson Center for Multiple Sclerosis Medicine Multiple sclerosis Immunology
108	Multiplehttp://msj.sagepub.com/ Sclerosis Journal Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS Robert J Fox, Alan Thompson, David Baker, Peer Baneke, Dou Add to Reading List Source URL: msj.sagepub.com Language: English Medicine Natalizumab Biogen Idec Multiple Sclerosis Journal National Multiple Sclerosis Society Corinne Goldsmith Dickinson Center for Multiple Sclerosis Dirucotide Multiple sclerosis Immune system Immunology
109	Microsoft Word - CT LIst 2011 Add to Reading List Source URL: www.nationalmssociety.org Language: English - Date: 2014-02-11 22:59:56 Multiple sclerosis Medicine Cytokines Autoimmune diseases Monoclonal antibodies Interferon beta-1a Therapies under investigation for multiple sclerosis Glatiramer acetate Biogen Idec Immunology Immune system Immunosuppressants
110	Clip and mail to your chapter of the National MS Society or to: National MS Society, Donor Services Center, P.O. Box 91891, Washington DC[removed]Name____________________________________________ Address_______________ Add to Reading List Source URL: www.nationalmssociety.org Language: English - Date: 2014-08-29 11:22:40 Medicine Autoimmune diseases Cytokines Neurological disorders Interferon beta-1a Pfizer Natalizumab Glatiramer acetate Biogen Idec Immunology Multiple sclerosis Immune system

UPDATE